Cue Biopharma (CUE) EBIT (2017 - 2025)
Cue Biopharma's (CUE) quarterly EBIT came in at $23.0 million in Q4 2025, down 1.19% year-on-year from $23.3 million in Q4 2024, and up 403.48% quarter-over-quarter from -$7.6 million in Q3 2025.
Cue Biopharma (CUE) EBIT (2017 - 2025) Analysis & Trends
Cue Biopharma has disclosed EBIT across 9 years of filings, most recently posting $23.0 million for Q4 2025.
- EBIT for Q4 2025 came in at $23.0 million, down 1.19% year-over-year; the trailing twelve-month figure through Dec 2025 was -$5.5 million (up 35.83% YoY), and the FY2025 annual result was -$5.5 million, up 35.83% from the prior year.
- EBIT came in at $23.0 million for Q4 2025 at Cue Biopharma, up from -$7.6 million in the prior quarter.
- In the past five years, EBIT ranged from a high of $23.3 million in Q4 2024 to a low of -$14.9 million in Q4 2022.
- The 5-year median for EBIT is -$11.9 million (2023), against an average of -$8.2 million.
- Across the five-year window, EBIT plunged 88.34% in 2022 and jumped 268.64% in 2024, its largest moves.
- Cue Biopharma's EBIT stood at -$7.9 million in 2021, then slumped by 88.34% to -$14.9 million in 2022, then increased by 6.96% to -$13.8 million in 2023, then surged by 268.64% to $23.3 million in 2024, then fell by 1.19% to $23.0 million in 2025.
- The last three EBIT figures came in at $23.0 million (Q4 2025), -$7.6 million (Q3 2025), and -$8.6 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.51 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Cue Biopharma | 581.16 Mn | 553.47 Mn | - | 23.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 23.05 Mn |
| Sep 30, 2025 | -7.60 Mn |
| Jun 30, 2025 | -8.64 Mn |
| Mar 31, 2025 | -12.30 Mn |
| Dec 31, 2024 | 23.33 Mn |
| Sep 30, 2024 | -8.82 Mn |
| Jun 30, 2024 | -10.38 Mn |
| Mar 31, 2024 | -12.67 Mn |
| Dec 31, 2023 | -13.83 Mn |
| Sep 30, 2023 | -11.42 Mn |
| Jun 30, 2023 | -13.52 Mn |
| Mar 31, 2023 | -13.38 Mn |
| Dec 31, 2022 | -14.87 Mn |
| Sep 30, 2022 | -11.03 Mn |
| Jun 30, 2022 | -13.09 Mn |
| Mar 31, 2022 | -14.24 Mn |
| Dec 31, 2021 | -7.89 Mn |
| Sep 30, 2021 | -13.02 Mn |
| Jun 30, 2021 | -10.30 Mn |
| Mar 31, 2021 | -12.52 Mn |